Stockreport

Vir Biotechnology to Present at Barclays Global Healthcare Conference

Vir Biotechnology, Inc.  (VIR) 
PDF SAN FRANCISCO, March 10, 2020 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on immune approaches to treating a [Read more]